Clinical Trial Update: Diagnostic Role of Serum Testican and Ubiquitin Levels in Patients With Head Trauma

View source ↗

Summary

A completed clinical trial evaluating serum Testican-1 and ubiquitin as potential diagnostic biomarkers for traumatic brain injury (head trauma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital | Conditions: Moderate Traumatic Brain Injury, Testican-1 | Status: COMPLETED